75 related articles for article (PubMed ID: 36245981)
1. Discovery of a T cell proliferation-associated regulator signature correlates with prognosis risk and immunotherapy response in bladder cancer.
Yan T; Zhou W; Li C
Int Urol Nephrol; 2024 May; ():. PubMed ID: 38789872
[TBL] [Abstract][Full Text] [Related]
2. Identification of a cisplatin resistant-based prognostic immune related gene signature in MIBC.
Wu Y; Xu Z; Fu G; Chen X; Tian J; Cai H; Jiang P; Jin B
Transl Oncol; 2024 Jun; 44():101942. PubMed ID: 38555741
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis and prognostic assessment of senescence-associated genes in bladder cancer.
Yang R; He J; Luo W; Xiang R; Zou G; Zhang X; Liu H; Deng J
Discov Oncol; 2024 Apr; 15(1):130. PubMed ID: 38668876
[TBL] [Abstract][Full Text] [Related]
4. Multi-omics analysis revealed the regulation mode of intratumor microorganisms and microbial signatures in gastrointestinal cancer.
Wang S; Liu P; Yu J; Liu T
Carcinogenesis; 2024 Mar; 45(3):149-162. PubMed ID: 37944024
[TBL] [Abstract][Full Text] [Related]
5. High expression of NXPH4 correlates with poor prognosis, metabolic reprogramming, and immune infiltration in colon adenocarcinoma.
Sun Z; Wang H; Xu Y; Liu Y; Wang L; Zhou R; Zhou R; Ma W; Zhang T
J Gastrointest Oncol; 2024 Apr; 15(2):641-667. PubMed ID: 38756632
[TBL] [Abstract][Full Text] [Related]
6. NXPH4 can be used as a biomarker for pan-cancer and promotes colon cancer progression.
Zhang Z; Wang P; Chen S; Xiang D; Chen J; Huang W; Liu X; Yi T; Wang D; Pu Y; He L; Zhang H
Aging (Albany NY); 2024 Apr; 16(7):5866-5886. PubMed ID: 38613793
[TBL] [Abstract][Full Text] [Related]
7. Forkhead box protein K1‑regulated neurexophilin 4 promotes proliferation, metastasis and glycolysis in colorectal cancer.
Fan Q; He W; Shang Y
Exp Ther Med; 2023 Sep; 26(3):434. PubMed ID: 37602314
[TBL] [Abstract][Full Text] [Related]
8. An m6A-Driven Prognostic Marker Panel for Renal Cell Carcinoma Based on the First Transcriptome-Wide m6A-seq.
Waldbillig F; Bormann F; Neuberger M; Ellinger J; Erben P; Kriegmair MC; Michel MS; Nuhn P; Nientiedt M
Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36899967
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients.
Zhang D; Wang M; Peng L; Yang X; Li K; Yin H; Xia C; Cui F; Huang H; Jin Z
J Oncol; 2021; 2021():4986227. PubMed ID: 34987579
[TBL] [Abstract][Full Text] [Related]
10. NXPH4 Used as a New Prognostic and Immunotherapeutic Marker for Muscle-Invasive Bladder Cancer.
Gui Z; Ying X; Liu C
J Oncol; 2022; 2022():4271409. PubMed ID: 36245981
[TBL] [Abstract][Full Text] [Related]
11. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
12. Multiomics analysis of ferroptosis-related molecular subtypes in muscle-invasive bladder cancer immunotherapy.
Wang H; Dai Y; Wu X; Hu B; Wang Z; Yan M
Transl Cancer Res; 2022 Nov; 11(11):4089-4104. PubMed ID: 36523302
[TBL] [Abstract][Full Text] [Related]
13. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
14. Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer.
Sun X; Xin S; Jin L; Zhang Y; Ye L
Bioengineered; 2022 May; 13(5):13986-13999. PubMed ID: 35758021
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]